IGM Biosciences Inc
NASDAQ:IGMS

Watchlist Manager
IGM Biosciences Inc Logo
IGM Biosciences Inc
NASDAQ:IGMS
Watchlist
Price: 8.99 USD 1.12% Market Closed
Market Cap: 533.3m USD
Have any thoughts about
IGM Biosciences Inc?
Write Note

Wall Street
Price Targets

IGMS Price Targets Summary
IGM Biosciences Inc

Wall Street analysts forecast IGMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IGMS is 19.99 USD with a low forecast of 9.09 USD and a high forecast of 50.4 USD.

Lowest
Price Target
9.09 USD
1% Upside
Average
Price Target
19.99 USD
122% Upside
Highest
Price Target
50.4 USD
461% Upside

IGMS Last Price Targets
IGM Biosciences Inc

The latest public price target was made on Oct 1, 2024 by Brian Abrahams from RBC Capital , who expects IGMS stock to rise by 89% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Brian Abrahams
RBC Capital
17 USD
Upside 89%
1 month ago
Oct 1, 2024
IGM Biosciences price target lowered to $17 from $20 at RBC Capital
TheFly
Asthika Goonewardene
Truist Financial
12 USD
Upside 33%
1 month ago
Oct 1, 2024
IGM Biosciences downgraded to Hold from Buy at Truist
TheFly
Stephen Willey
Stifel Nicolaus
25 USD
Upside 178%
1 month ago
Oct 1, 2024
Stifel Reiterates Buy Rating on IGM Biosciences (IGMS)
StreetInsider
Robert Driscoll
Wedbush
25 USD
Upside 178%
3 months ago
Aug 15, 2024
IGM Biosciences price target raised to $25 from $20 at Wedbush
TheFly
Michael Ulz
Morgan Stanley
12 USD
Upside 33%
3 months ago
Aug 14, 2024
Morgan Stanley Reiterates Overweight Rating on IGM Biosciences (IGMS)
StreetInsider
Brian Abrahams
RBC Capital
20 USD
Upside 122%
6 months ago
May 9, 2024
IGM Biosciences (IGMS) PT Lowered to $20 at RBC Capital
StreetInsider
Show More Price Targets
Show Less Price Targets
Brian Abrahams
RBC Capital
Price Target 17 USD
Upside/Downside 89%
View Source
Asthika Goonewardene
Truist Financial
Price Target 12 USD
Upside/Downside 33%
View Source
Stephen Willey
Stifel Nicolaus
Price Target 25 USD
Upside/Downside 178%
View Source
Robert Driscoll
Wedbush
Price Target 25 USD
Upside/Downside 178%
View Source
Michael Ulz
Morgan Stanley
Price Target 12 USD
Upside/Downside 33%
View Source
Brian Abrahams
RBC Capital
Price Target 20 USD
Upside/Downside 122%
View Source
Show More Price Targets
Show Less Price Targets
IGM Biosciences Inc Competitors:
Price Targets
LCTX
Lineage Cell Therapeutics Inc
684% Upside
RARE
Ultragenyx Pharmaceutical Inc
100% Upside
TVTX
Travere Therapeutics Inc
49% Upside
HOWL
Werewolf Therapeutics Inc
548% Upside
REGN
Regeneron Pharmaceuticals Inc
48% Upside
ALLK
Allakos Inc
224% Upside
377740
BioNote Inc
26% Upside
ELDN
Eledon Pharmaceuticals Inc
209% Upside

Revenue
Forecast

Revenue Estimate
IGM Biosciences Inc

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 121%.

N/A
Past Growth
121%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
IGM Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IGMS's stock price target?
Price Target
19.99 USD

According to Wall Street analysts, the average 1-year price target for IGMS is 19.99 USD with a low forecast of 9.09 USD and a high forecast of 50.4 USD.

What is IGM Biosciences Inc's Revenue forecast?
Projected CAGR
121%

The compound annual growth rate of IGM Biosciences Inc's revenue for the next 3 years is 121%.

Back to Top